CHA2DS2-VASc calculations in patients with atrial fibrillation receiving oral anticoagulants in Scotland

Tools

Zeng, Wenjie and Mueller, Tanja and Godman, Brian and Alvarez-Madrazo, Samantha and Bennie, Marion (2017) CHA2DS2-VASc calculations in patients with atrial fibrillation receiving oral anticoagulants in Scotland. International Journal of Population Data Science, 1 (1). 267. (https://doi.org/10.23889/ijpds.v1i1.287)

[thumbnail of Wenjie-etal-IJPDS-2017-CHA2DS2-VASc-calculations-in-patients-with-atrial-fibrillation-receiving-oral-anticoagulants]
Preview
 Text. Filename: Wenjie_etal_IJPDS_2017_CHA2DS2_VASc_calculations_in_patients_with_atrial_fibrillation_receiving_oral_anticoagulants.pdf
Final Published Version
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo
Download (213kB)| Preview

Abstract

Patients with atrial fibrillation (AF) have an increased risk of developing stroke, and oral anticoagulants (OACs) are commonly used in stroke prevention. The CHA2DS2-VASc score has been proved to be a simple and effective tool for stroke risk assessment which guides the selection of treatment with OACs. This score is calculated using disease diagnoses; however, a range of different versions exist, making comparability questionable.The aim of this study was to compare CHA2DS2-VASc scores in OAC treated patients with a hospital-confirmed diagnosis of AF in Scotland using different subsets of ICD-10 codes.

ORCID iDs

Zeng, Wenjie, Mueller, Tanja ORCID logoORCID: https://orcid.org/0000-0002-0418-4789, Godman, Brian, Alvarez-Madrazo, Samantha and Bennie, Marion ORCID logoORCID: https://orcid.org/0000-0002-4046-629X;
CORE (COnnecting REpositories)